0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover403.27%IV47.64%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.0540Delta0.0607Gamma76.40Leverage Ratio-0.0187Theta0.0000Rho-4.12Eff Leverage0.0005Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet